ISSN 1662-4009 (online)

ey0021.1-12 | New Treatments and Hopes | ESPEYB21

1.12. Insights into central congenital hypothyroidism: A multicenter retrospective analysis

A German , S Almashanu , Vries L de , Margolis M Gil , R Halloun , A Haim , O Eyal , F Levy-Khademi , D Pivko-Levy , J Nir , O Pinhas-Hamiel , Y Tenenbaum-Rakover

Brief Summary: This multicentre retrospective cross-sectional study provides critical insights into the epidemiology, clinical presentation, and neurodevelopmental outcomes of central congenital hypothyroidism (CCH).CCH is a rare disorder that occurs due to insufficient hypothalamic-pituitary stimulation of the thyroid, characterized by low total T4 (TT4) with either low, normal or slightly elevated TSH. Most newborn screening (NBS) programs for CH are p...

ey0021.2-3 | Epigenetics | ESPEYB21

2.3. Trophectoderm biopsy of blastocysts following IVF and embryo culture increases epigenetic dysregulation in a mouse model

EA Rhon-Calderon , CN Hemphill , LA Vrooman , CL Rosier , Y Lan , T Ord , C Coutifaris , M Mainigi , RM Schultz , MS Bartolomei

Brief Summary: This study compared the histology and growth phenotypes, epigenotypes and gene expression profiles of mouse embryos, embryonic livers, and placental tissue at differing gestational ages after exposure to IVF. They followed the growth and metabolic profiles (glucose, insulin, triglycerides, total cholesterol, HDL, LDL/VLDL) of offspring to age 12 weeks. Groups analysed by sex included those conceived naturally, by IVF, by IVF with TEBx (trophectoderm biopsy) and ...

ey0021.9-11 | Thyroid Issues in Cancer Survivors | ESPEYB21

9.11. Thyroid ultrasound screening in childhood cancer survivors following radiotherapy

JA Baran , S Halada , AJ Bauer , Y Li , A Isaza , T Patel , L Sisko , JP Ginsberg , K Kazahaya , NS Adzick , S Mostoufi-Moab

Brief Summary: This retrospective study assessed the outcome of thyroid ultrasound (US) surveillance in childhood cancer survivors (CCS) exposed to radiotherapy (RT). 306 CCS were monitored with thyroid US. Patients received TBI (45%) and/or RT to craniospinal (44%), chest (11%), and neck regions (6%). Thyroid US surveillance was started at a median interval of 9.1 years after RT; 150 patients (49%) had thyroid nodule(s); 44 patients underwent surgery, and 28 had a final diagn...

ey0021.14-18 | YES contributions by Dr. Simge Eren (14.17 and 14.18) | ESPEYB21

14.18. EPAC1 enhances brown fat growth and beige adipogenesis

Reverte-Salisa Laia , Siddig Sana , Hildebrand Staffan , Yao Xi , Zurkovic Jelena , Jaeckstein Michelle Y. , Heeren Joerg , Lezoualc'h Frank , Krahmer Natalie , Pfeifer Alexander

Brief Summary:This basic science study, using mice, cell models, and organoids, shows that the cAMP-binding protein EPAC1 is a central regulator of adaptive brown adipose tissue (BAT). EPAC1 specifically increases the number of thermogenic fat cells (brown and beige adipocytes), by promoting the differentiation and growth of brown adipocytes and the development of beige adipocytes through signaling pathways that enhance lipid metabolism and thermogenesis.<p class="abstext"...

ey0021.15-3 | New Treatments | ESPEYB21

15.3. Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial

AM Jastreboff , LM Kaplan , JP Frias , Q Wu , Y Du , S Gurbuz , T Coskun , A Haupt , Z Milicevic , ML Hartman , for the Retatrutide Phase 2 Obesity Trial Investigators.

In Brief: This phase 2 trial randomized 338 adults with overweight or obesity to once-weekly subcutaneous Retatrutide (LY3437943), a ‘triple agonist’ for glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide 1 (GLP1), and glucagon receptors, or placebo. Mean % change in body weight at 24 weeks was −7.2%, −12.9%, −17.3% and −17.5% in the 1-mg, 4-mg, 8-mg and 12-mg Retatrutide groups, compared with −1.6% in the placebo ...

ey0019.5-3 | Novel treatments for rare skeletal disorders | ESPEYB19

5.3. Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study

R Savarirayan , L Tofts , M Irving , WR Wilcox , CA Bacino , J Hoover-Fong , RU Font , P Harmatz , F Rutsch , MB Bober , LE Polgreen , I Ginebreda , K Mohnike , J Charrow , D Hoernschemeyer , K Ozono , Y Alanay , P Arundel , Y Kotani , N Yasui , KK White , HM Saal , A Leiva-Gea , F Luna-Gonzalez , H Mochizuki , D Basel , DM Porco , K Jayaram , E Fisheleva , A Huntsman-Labed , JRS Day

Genet Med. 2021 Dec;23(12):2443-2447.Abstract: https://pubmed-ncbi-nlm-nih-gov.proxy.kib.ki.se/34341520/In brief: In achondroplasia, longitudinal bone growth is inhibited resulting in severe, disproportionate short stature. In this open-label extension study of participants from the phase 3 study, daily subcutaneous injection of vosoritide during 104 weeks resulted in increa...

ey0019.10-9 | Advances in clinical practice | ESPEYB19

10.9. Comparison of insulin dose adjustments made by artificial intelligence based decision support system and by physicians in people with type 1 diabetes using multiple daily injections therapy

R Nimri , A Tirosh , I Muller , Y Shtrit , I Kraljević , MM Alonso , T Milicic , B Saboo , A Deeb , A Christoforidis , Brinker M den , L Bozzetto , AM Bolla , M Krcma , RA Rabini , S Tabba , A Vazeou-Gerasimidi , G Maltoni , E Giani , I Dotan , IF Liberty , Y Toledano , O Kordonouri , N Bratina , K Dovc , T Biester , E Atlas , M Phillip

Diabetes Technol Ther. 2022;24:564-572. doi: https://pubmed.ncbi.nlm.nih.gov/35325567/Brief Summary: This physician survey-based study compared insulin dose recommendations between an artificial intelligence-based decision support system (ED-DSS) and 20 experienced physicians from 11 countries. Using data from 17 individuals with type 1 diabetes (T1D) treated with multiple daily insulin inj...

ey0019.14-9 | Risk and Outcome | ESPEYB19

14.9. A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

SA Williams , R Ostroff , MA Hinterberg , J Coresh , CM Ballantyne , K Matsushita , CE Mueller , J Walter , C Jonasson , RR Holman , SH Shah , N Sattar , R Taylor , ME Lean , S Kato , H Shimokawa , Y Sakata , K Nochioka , CR Parikh , SG Coca , T Omland , J Chadwick , D Astling , Y Hagar , N Kureshi , K Loupy , C Paterson , J Primus , M Simpson , NP Trujillo , P Ganz

Sci Transl Med. 2022 Apr 6;14(639):eabj9625; PMID 35385337 doi: 10.1126/scitranslmed.abj9625https://www.science.org/doi/10.1126/scitranslmed.abj9625Brief Summary: This international study, led by Dr. Stephens Williams from Boulder, Colorado, USA, developed a surrogate biomarker from 27 circulating proteins to predict ...

ey0017.1-5 | Hypopituitarism: Disease Modeling and New Discoveries | ESPEYB17

1.5. Hypothalamic contribution to pituitary functions is recapitulated in vitro using 3D-cultured human iPS cells

T Kasai , H Suga , Sakakibara , C Ozone , R Matsumoto , M Kano , K Mitsumoto , K Ogawa , Y Kodani , H Nagasaki , N Inoshita , M Sugiyama , T Onoue , T Tsunekawa , Y Ito , H Takagi , D Hagiwara , S Iwama , M Goto , R Banno , R Takahashi , H Arima

To read the full abstract: Cell Rep. 2020 Jan 7;30(1):18–24.e5. doi: 10.1016/j.celrep.2019.12.009. PMID: 31914385.The hypothalamic-pituitary axis influences many body organ systems and its dysfunction can be fatal. A proper in vitro model is important for understanding the disease mechanisms affecting pituitary function. Based on their previous anterior pituitary modelli...

ey0017.7-11 | Basic Science | ESPEYB17

7.11. Neuron-derived neurotrophic factor is mutated in congenital hypogonadotropic hypogonadism

A Messina , K Pulli , S Santini , J Acierno , J Kansakoski , D Cassatella , C Xu , F Casoni , SA Malone , G Ternier , D Conte , Y Sidis , J Tommiska , K Vaaralahti , A Dwyer , Y Gothilf , GR Merlo , F Santoni , NJ Niederlander , P Giacobini , T Raivio , N Pitteloud

To read the full abstract: American journal of human genetics vol. 106,1 (2020): 58–70. doi: https://www.sciencedirect.com/science/article/pii/S0002929719304677?via%3DihubBy performing next-generation sequencing in 240 unrelated probands with congenital hypogonadotropic hypogonadism and follow-up in multiple animal models, this study identifies ...